Literature DB >> 16464866

Identification and functional characterization of a presqualene diphosphate phosphatase.

Koichi Fukunaga1, Makoto Arita, Minoru Takahashi, Andrew J Morris, Michael Pfeffer, Bruce D Levy.   

Abstract

Presqualene diphosphate (PSDP) is a bioactive lipid that rapidly remodels to presqualene monophosphate (PSMP) upon cell activation (Levy, B. D., Petasis, N. A., and Serhan, C. N. (1997) Nature 389, 985-990). Here, we have identified and characterized a phosphatase that converts PSDP to PSMP. Unlike the related polyisoprenyl phosphate farnesyl diphosphate (FDP), PSDP was not a substrate for type 2 lipid phosphate phosphohydrolases. PSDP phosphatase activity was identified in activated human neutrophil (PMN) extracts and partially purified in the presence of Nonidet P-40 with gel filtration and anion exchange chromatography. Peptide sequencing of a candidate phosphatase was consistent with phosphatidic acid phosphatase domain containing 2 (PPAPDC2), an uncharacterized protein that contains a lipid phosphate phosphohydrolase consensus motif. Recombinant PPAPDC2 displayed diphosphate phosphatase activity with a substrate preference for PSDP > FDP > phosphatidic acid. PPAPDC2 activity was independent of Mg(2+) and optimal at pH 7.0 to 8.0. Incubation of [(14)C]FDP with recombinant human squalene synthase led to [(14)C]PSDP and [(14)C]squalene formation, and in the presence of PPAPDC2, [(14)C]PSMP was generated from [(14)C]PSDP. PPAPDC2 mRNA was detected in human PMN, and is widely expressed in human tissues. Together, these findings indicate that PPAPDC2 in human PMN is the first lipid phosphate phosphohydrolase identified for PSDP. Regulation of this activity of the enzyme may have important roles for PMN activation in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464866     DOI: 10.1074/jbc.M512970200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Design and synthesis of non-hydrolyzable homoisoprenoid α-monofluorophosphonate inhibitors of PPAPDC family integral membrane lipid phosphatases.

Authors:  Thangaiah Subramanian; Hongmei Ren; Karunai Leela Subramanian; Manjula Sunkara; Fredrick O Onono; Andrew J Morris; H Peter Spielmann
Journal:  Bioorg Med Chem Lett       Date:  2014-08-12       Impact factor: 2.823

Review 2.  Endogenous lipid mediators in the resolution of airway inflammation.

Authors:  O Haworth; B D Levy
Journal:  Eur Respir J       Date:  2007-11       Impact factor: 16.671

Review 3.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

Review 4.  Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

Authors:  Nandini Krishnamoorthy; Raja-Elie E Abdulnour; Katherine H Walker; Braden D Engstrom; Bruce D Levy
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 5.  Lipid mediators as agonists for the resolution of acute lung inflammation and injury.

Authors:  Caroline Bonnans; Bruce D Levy
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-21       Impact factor: 6.914

6.  Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells.

Authors:  Sumitra Miriyala; Thangaiah Subramanian; Manikandan Panchatcharam; Hongmei Ren; Mark I McDermott; Manjula Sunkara; Tracy Drennan; Susan S Smyth; H Peter Spielmann; Andrew J Morris
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

7.  Sumoylation regulates nuclear localization of lipin-1alpha in neuronal cells.

Authors:  Guang-Hui Liu; Larry Gerace
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

8.  Regulation of myoblast differentiation by the nuclear envelope protein NET39.

Authors:  Guang-Hui Liu; Tinglu Guan; Kaustuv Datta; Judith Coppinger; John Yates; Larry Gerace
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

9.  Activation of polyisoprenyl diphosphate phosphatase 1 remodels cellular presqualene diphosphate.

Authors:  Troy Carlo; Nicos A Petasis; Bruce D Levy
Journal:  Biochemistry       Date:  2009-04-07       Impact factor: 3.162

10.  Suppression of CYP2B induction by alendronate-mediated farnesyl diphosphate synthase inhibition in primary cultured rat hepatocytes.

Authors:  Nancy M Jackson; Thomas A Kocarek
Journal:  Drug Metab Dispos       Date:  2008-07-10       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.